Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Califano

Showing results (311-320 of 336) with videos related to

Pageof 34
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinomaAndré Lopes Carvalho, Carmen Jeronimo, Michael M Kim, et al.
International Journal of Cancer|April 11, 2015
NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinomaDaria A Gaykalova, Judith B Manola, Hiroyuki Ozawa, et al.
Journal of the American Academy of Dermatology|January 25, 2011
A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristicsSharifeh Farasat, Siegrid S Yu, Victor A Neel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2015
Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinomaJoseph A Califano, Zubair Khan, Kimberly A Noonan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2018
Correction: Tadalafil Augments Tumor-specific Immunity in Patients with Head and Neck Squamous Cell CarcinomaJoseph A Califano, Zubair Khan, Kimberly A Noonan, et al.
Scientific Reports|June 27, 2017
Corrigendum: A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinomaAneesha Radhakrishnan, Vishalakshi Nanjappa, Remya Raja, et al.
Scientific Reports|November 1, 2016
A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinomaAneesha Radhakrishnan, Vishalakshi Nanjappa, Remya Raja, et al.
Cancer Research|October 5, 2006
Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinomaAndré Lopes Carvalho, Alice Chuang, Wei-Wen Jiang, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 18, 2018
Functional characterization of alternatively spliced GSN in head and neck squamous cell carcinomaDylan Z Kelley, Emily L Flam, Theresa Guo, et al.
International Journal of Otolaryngology|November 3, 2012
Multidisciplinary service utilization pattern by advanced head and neck cancer patients: a single institution studyJacqueline C Junn, Irene A Kim, Marianna L Zahurak, et al.
Pageof 34

Showing results (311-320 of 336) with videos related to

Sort By:
Pageof 34
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinomaAndré Lopes Carvalho, Carmen Jeronimo, Michael M Kim, et al.
International Journal of Cancer|April 11, 2015
NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinomaDaria A Gaykalova, Judith B Manola, Hiroyuki Ozawa, et al.
Journal of the American Academy of Dermatology|January 25, 2011
A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristicsSharifeh Farasat, Siegrid S Yu, Victor A Neel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2015
Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinomaJoseph A Califano, Zubair Khan, Kimberly A Noonan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2018
Correction: Tadalafil Augments Tumor-specific Immunity in Patients with Head and Neck Squamous Cell CarcinomaJoseph A Califano, Zubair Khan, Kimberly A Noonan, et al.
Scientific Reports|June 27, 2017
Corrigendum: A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinomaAneesha Radhakrishnan, Vishalakshi Nanjappa, Remya Raja, et al.
Scientific Reports|November 1, 2016
A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinomaAneesha Radhakrishnan, Vishalakshi Nanjappa, Remya Raja, et al.
Cancer Research|October 5, 2006
Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinomaAndré Lopes Carvalho, Alice Chuang, Wei-Wen Jiang, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 18, 2018
Functional characterization of alternatively spliced GSN in head and neck squamous cell carcinomaDylan Z Kelley, Emily L Flam, Theresa Guo, et al.
International Journal of Otolaryngology|November 3, 2012
Multidisciplinary service utilization pattern by advanced head and neck cancer patients: a single institution studyJacqueline C Junn, Irene A Kim, Marianna L Zahurak, et al.
Pageof 34